Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis (Q58857634)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2006

Language	Label	Description	Also known as
English	Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis	scientific article published on 01 August 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

multiple sclerosis

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Tilbery CP

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Monteiro LP

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Teixeira MM

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Teixeira AL

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Acta Neurologica Scandinavica

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

109-113

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Pulsed intravenous methylprednisolone therapy in progressive multiple sclerosis: need for a controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Chemokines: immunology's high impact factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Chemokines: multiple levels of leukocyte migration control.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

The chemokine system in neuroinflammation: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00629.X

21 January 2018

Identifiers

10.1111/J.1600-0404.2006.00629.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16867033%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58857634&oldid=2153367402"